2014

KEMET Reports Preliminary Financial Information for the Fourth Quarter and Fiscal Year 2013

GREENVILLE, S.C., May 9, 2013 /PRNewswire/ -- KEMET Corporation ("KEMET" or the "Company") (NYSE: KEM) today reported preliminary results for the fourth fiscal quarter and fiscal year ended March 31, 2013, before our anticipated loss from our 34% equity interest related to NEC TOKIN.  Net sales for fiscal year ended March 31, 2013 were $843.0 million which is a 14.4% decrease over the same period last fiscal year. 

On a U.S. GAAP basis, for the fiscal year ended March 31, 2013, net loss before our equity loss from NEC TOKIN was $80.9 million, or $(1.80) per basic and diluted share compared to net income of $6.7 million or $0.13 per diluted share for fiscal year ended March 31, 2012.  Fiscal years 2013 and 2012 include various items affecting comparability as denoted in the U.S. GAAP to Non-U.S. GAAP reconciliation below.

Non-GAAP adjusted net loss before our anticipated loss from NEC TOKIN for the fiscal year ended March 31, 2013 was $27.0 million, or $(0.60) per basic and diluted share compared to adjusted net income of $54.5 million or $1.04 per diluted share for the fiscal year ended March 31, 2012.  Adjusted EBITDA for the fiscal years ended March 31, 2013 and 2012 was $59.8 million and $128.4, respectively.

On February 1, 2013 the Company's wholly owned subsidiary, KEMET Electronics Corporation completed the acquisition of 34% economic interest (51% voting common stock interest) in NEC TOKIN Corporation.  The ownership interest in NEC TOKIN is treated as an equity method investment and as such the Company will report the 34% interest in the profit or loss of NEC TOKIN.  The net loss from NEC TOKIN for the two month period ended March 31, 2013 is not yet available.

Net sales for the quarter ended March 31, 2013 were $203.0 million which is a 3.6% decrease over the same quarter last fiscal year.  On a U.S. GAAP basis, for the fourth fiscal quarter of fiscal year 2013, net loss before equity loss from NEC TOKIN was $24.0 million, or $(0.53) per basic and diluted share compared to net loss of $11.7 million or $(0.26) per basic and diluted share for the same quarter last year.  The fourth quarters of fiscal year 2013s, and 2012 includes various items affecting comparability as denoted in the U.S. GAAP to Non-U.S. GAAP reconciliation below.

Non-GAAP adjusted net loss, before our anticipated loss from NEC TOKIN, was $9.8 million or $(0.22) per basic and diluted share for the fourth quarter of fiscal year 2013 compared to $7.0 million of adjusted net loss or $(0.16) per diluted share for the same quarter last year.  Adjusted EBITDA for the quarter ended March 31, 2013 was $11.4 million as compared to $9.7 million for the quarter ended March 31, 2012.

Per Loof, KEMET's Chief Executive Officer, stated, "Revenue remained more or less flat to our prior quarter as forecasted and seems to have leveled off at this level for at least one more quarter. The team remains focused on delivering improved financial results even as the industry remains trapped by an economy that is moving sideways.  We expect to see benefits during our next fiscal year from our relationship with NEC TOKIN primarily related to our recently signed PLP and cross-licensing agreements.  We are optimistic that we can build significant shareholder value from our recent equity investment."

About KEMET

The Company's common stock is listed on the NYSE under the ticker symbol "KEM" (NYSE: KEM).  At the Investor Relations section of our web site at http://www.kemet.com/IR, users may subscribe to KEMET news releases and find additional information about our Company.  KEMET applies world class service and quality to deliver industry leading, high performance capacitance solutions to its customers around the world and offers the world's most complete line of surface mount and through hole capacitor technologies across tantalum, ceramic, film, aluminum, electrolytic, and paper dielectrics. Additional information about KEMET can be found at http://www.kemet.com.

 

Contact:

William M. Lowe, Jr.

Dean W. Dimke


 

Executive Vice President and

Senior Director of Corporate and


 

Chief Financial Officer

Investor Communications


 

williamlowe@kemet.com 

deandimke@kemet.com


 

864-963-6484

954-766-2800

 

QUIET PERIOD

Beginning July 1, 2013, we will observe a quiet period during which the information provided in this news release and our annual report on Form 10-K will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.

CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about KEMET Corporation's (the "Company") financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates," variations of such words and other similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.

Factors that may cause actual outcome and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following:

(i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) adverse economic conditions could cause the write down of long-lived assets or goodwill; (iii) an increase in the cost or a decrease in the availability of our principal or single-sourced purchased materials; (iv) changes in the competitive environment; (v) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vi) economic, political, or regulatory changes in the countries in which we operate; (vii) difficulties, delays or unexpected costs in completing the restructuring plan; (viii) equity method investments expose us to a variety of risks; (ix) acquisitions and other strategic transactions expose us to a variety of risks; (x)  the inability to attract, train and retain effective employees and management; (xi) the inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xii) exposure to claims alleging product defects; (xiii) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xiv) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xv) volatility of financial and credit markets affecting our access to capital; (xvi) the need to reduce the total costs of our products to remain competitive; (xvii) potential limitation on the use of net operating losses to offset possible future taxable income; (xviii) restrictions in our debt agreements that limit our flexibility in operating our business; and (xix) additional exercise of the warrant by K Equity, LLC which could potentially result in the existence of a significant stockholder who could seek to influence our corporate decisions.

 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations - Highlights

(Amounts in thousands, except per share data)

(Unaudited)


 

 

 

 

 

 

 

 

 

 

Quarters Ended


 

Fiscal Years Ended


 

 

 

 

 

 

 

 

 

March 31, 2013


 

March 31, 2012


 

March 31, 2013


 

March 31, 2012


 

 

 

 

 

 

 

 

 

 

Net sales


 

$             203,034


 

$      210,668


 

$         842,954


 

$      984,833


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales


 

175,867


 

183,542


 

716,358


 

775,670


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)


 

(15,927)


 

(9,992)


 

(39,282)


 

37,801


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes and equity loss from NEC TOKIN


 

(24,652)


 

(15,849)


 

(77,610)


 

8,444

Income tax expense (benefit)


 

(655)


 

(4,145)


 

3,318


 

1,752

Income (loss) before equity loss from NEC TOKIN


 

$             (23,997)


 

$       (11,704)


 

$          (80,928)


 

$          6,692


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share before equity loss from NEC TOKIN (basic)


 

$                 (0.53)


 

$           (0.26)


 

$              (1.80)


 

$            0.15

Net income (loss) per share before equity loss from NEC TOKIN (diluted)


 

$                 (0.53)


 

$           (0.26)


 

$              (1.80)


 

$            0.13


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding:


 

 

 

 

 

 

 

 

 

     Basic


 

44,953


 

44,662


 

44,897


 

43,285

     Diluted


 

44,953


 

44,662


 

44,897


 

52,320

 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets - Highlights

(Amounts in thousands, except per share data)


 

 

 

 

 

 

 

 

 

 

 

March 31,


 

 

 

 

 

 

 

 

 

 

2013


 

2012


 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents


 

$           95,978


 

$         210,521

Accounts receivable, net


 

96,564


 

104,950

Inventories, net


 

205,615


 

212,234


 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable


 

73,669


 

74,404


 

 

 

 

 

 

 

 

 

 

 

 

 

Short-term debt


 

10,793


 

1,951

Long-term debt


 

369,990


 

341,841

Debt premium


 

2,717


 

3,539

Total debt


 

383,500


 

347,331


 

 

 

 

 

 

 

 

 

 

 

 

 

Total stockholders' equity


 

276,760


 

358,996

 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Cash Flows - Highlights

(Amounts in thousands)

(Unaudited)


 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended March 31,


 

 

 

 

 

 

 

 

 

2013


 

2012


 

2011

Net cash (used in) provided by operating activities


 

$      (22,827)


 

$        80,730


 

$      113,968


 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital expenditures


 

(46,174)


 

(49,314)


 

(34,989)

Investment in NEC TOKIN


 

(50,917)


 

-


 

-

Change in restricted cash


 

(15,284)


 

-


 

-


 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from issuance of debt


 

39,825


 

116,050


 

227,525

Deferred acquisition payments


 

(16,900)


 

-


 

-


 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalents


 

(113,952)


 

59,169


 

71,066

 

Non-U.S. GAAP Financial Measures

In this news release, the Company makes reference to certain Non-U.S. GAAP financial measures, including "Adjusted net income (loss) before equity loss from NEC TOKIN", "Adjusted net income (loss) before equity loss from NEC TOKIN per share" and "Adjusted EBITDA".  Management believes that investors may find it useful to review the Company's financial results as adjusted to exclude items as determined by management.

Adjusted Net Income (Loss) Before Equity Loss From NEC TOKIN and Adjusted Net Income (Loss) Before Equity Loss From NEC TOKIN Per Share

"Adjusted net income (loss) before equity loss from NEC TOKIN" and "Adjusted net income (loss) before equity loss from NEC TOKIN per share" represent net income (loss) before equity loss from NEC TOKIN and net income (loss) before equity loss from NEC TOKIN per share excluding write down of long-lived assets, restructuring charges related primarily to equipment moves and employee severance, plant start-up costs, amortization related to debt issuance costs and debt discount, net gain/loss on sales and disposals of assets, ERP integration costs, stock-based compensation expense, net foreign exchange gain/loss, inventory write-downs, registration related fees, acquisition related fees, gain on licensing of patents, loss on early extinguishment of debt, income tax expense related to foreign tax law changes which limit the utilization of net operating losses, curtailment and settlement gain on benefit plans, goodwill impairment and income tax effect on non-GAAP adjustments.  Management believes that these Non-U.S. GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company.  Management uses these Non-U.S. GAAP financial measures to evaluate operating performance.  Non-U.S. GAAP financial measures should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP.

The following table provides reconciliation from U.S. GAAP net income (loss) before equity loss from NEC TOKIN to Non-U.S. GAAP adjusted net income (loss) before equity loss from NEC TOKIN:

 


 

 

GAAP to Non-GAAP Reconciliation


 

 

(Unaudited)


 

 

 

 

 

 

 

 

 

 

 

 

 

Quarters Ended


 

Fiscal Years Ended


 

 

March 31, 2013


 

December 31, 2012


 

March 31, 2012


 

March 31, 2013


 

March 31, 2012


 

 

(Amounts in thousands, except per share data)

Including adjustments (GAAP)


 

 

 

 

 

 

 

 

 

 

Net sales


 

$           203,034


 

$             200,297


 

$          210,668


 

$       842,954


 

$      984,833


 

 

 

 

 

 

 

 

 

 

 

Net income (loss) before equity loss from NEC TOKIN


 

$           (23,997)


 

$             (14,257)


 

$          (11,704)


 

$        (80,928)


 

$          6,692

Net income (loss) before equity loss from NEC TOKIN per share (basic)


 

$               (0.53)


 

$                 (0.32)


 

$              (0.26)


 

$            (1.80)


 

$            0.15

Net income (loss) before equity loss from NEC TOKIN per share (diluted)


 

$               (0.53)


 

$                 (0.32)


 

$              (0.26)


 

$            (1.80)


 

$            0.13


 

 

 

 

 

 

 

 

 

 

 

Excluding the following items (Non-GAAP)


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) before equity loss from NEC TOKIN


 

$           (23,997)


 

$             (14,257)


 

$          (11,704)


 

$        (80,928)


 

$          6,692

 Adjustments: 


 

 

 

 

 

 

 

 

 

 

         Restructuring charges 


 

5,047


 

3,886


 

876


 

18,719


 

14,254

         Acquisition related fees


 

3,009


 

164


 

866


 

4,581


 

1,476

         ERP integration costs


 

2,469


 

1,458


 

2,772


 

7,702


 

7,707

         Net curtailment and settlement gain on benefit plans


 

1,354


 

587


 

-


 

266


 

-

         Plant start-up costs


 

1,307


 

1,524


 

2,190


 

6,122


 

3,574

         Stock-based compensation expense


 

1,015


 

1,078


 

1,697


 

4,599


 

3,075

         Amortization included in interest expense


 

1,092


 

1,122


 

696


 

4,138


 

3,599

         Net foreign exchange (gain) loss


 

(911)


 

(464)


 

(652)


 

(28)


 

919

         Write down of long lived assets


 

264


 

3,084


 

-


 

7,582


 

15,786

         Loss (gain) on sales and disposals of assets


 

141


 

(196)


 

226


 

18


 

318

         Registration related fees


 

-


 

-


 

-


 

20


 

281

         Goodwill impairment


 

-


 

-


 

-


 

1,092


 

-

         Income tax effect of non-GAAP adjustments (1)


 

(591)


 

(228)


 

(3,991)


 

(906)


 

(3,203)


 

 

 

 

 

 

 

 

 

 

 

 Adjusted net income (loss) before equity loss from NEC TOKIN  


 

 

 

 

 

 

 

 

 

 

         (excluding adjustments)


 

$             (9,801)


 

$               (2,242)


 

$            (7,024)


 

$        (27,023)


 

$        54,478

 Adjusted net income (loss) before equity loss from NEC TOKIN per  


 

 

 

 

 

 

 

 

 

 

         basic share (excluding adjustments) 


 

$               (0.22)


 

$                 (0.05)


 

$              (0.16)


 

$            (0.60)


 

$            1.26

 Adjusted net income (loss) before equity loss from NEC TOKIN per  


 

 

 

 

 

 

 

 

 

 

         diluted share (excluding adjustments)


 

$               (0.22)


 

$                 (0.05)


 

$              (0.16)


 

$            (0.60)


 

$            1.04

 

(1)

The income tax effect of the excluded items is calculated by applying the applicable jurisdictional income tax rate, considering the deferred tax valuation for each applicable jurisdiction, and includes the income tax affect of law changes related to the utilization of net operating loss carryforwards. 

 

Adjusted EBITDA

Adjusted EBITDA represents net income (loss) before equity loss from NEC TOKIN, income tax expense (benefit), net interest expense, and depreciation and amortization expense, adjusted to exclude: restructuring charges, write down of long-lived assets, ERP integration costs, plant start-up costs, stock-based compensation expense, goodwill impairment, acquisition related fees, net curtailment and settlement gain/loss on benefit plans, net foreign exchange gain/loss, net loss on sales and disposals of assets and registration related fees.  We use Adjusted EBITDA to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business.  We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt.  We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.

We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other items excluded from Adjusted EBITDA are excluded in order to better reflect our continuing operations.

In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments noted below.  Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments.  Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.

Our Adjusted EBITDA measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.  Some of these limitations are:

  • it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;

     
  • it does not reflect changes in, or cash requirements for, our working capital needs;

     
  • it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;

     
  • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements;

     
  • it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;

     
  • it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations;

     
  • it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and

     
  • other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations.  You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementally.

The following tables provide a reconciliation from U.S. GAAP net income (loss) before equity loss from NEC TOKIN to Adjusted EBITDA (amounts in thousands):

 


 

Fiscal Year 2013


 

Q1

Q2

Q3

Q4

Total

Net loss before equity loss from NEC TOKIN

$      (17,753)

$      (24,921)

$      (14,257)

$      (23,997)

$      (80,928)


 

 

 

 

 

 

Adjustments:


 

 

 

 

 

Income tax expense (benefit)

1,771

1,787

415

(655)

3,318

Interest expense, net

10,426

10,110

10,193

10,463

41,192

Depreciation and amortization expense

11,656

11,521

10,502

11,880

45,559

Restructuring charges

1,264

8,522

3,886

5,047

18,719

Write down of long lived assets

-

4,234

3,084

264

7,582

ERP integration costs

1,676

2,099

1,458

2,469

7,702

Plant start-up costs

1,361

1,930

1,524

1,307

6,122

Acquisition related fees

542

866

164

3,009

4,581

Stock-based compensation expense

1,264

1,242

1,078

1,015

4,599

Goodwill impairment

-

1,092

-

-

1,092

Loss (gain) on sales and disposals of assets

104

(31)

(196)

141

18

Net curtailment and settlement gain on benefit plans

-

(1,675)

587

1,354

266

Net foreign exchange loss (gain)

1,789

(442)

(464)

(911)

(28)

Registration related fees

20

-

-

-

20

Adjusted EBITDA

$        14,120

$        16,334

$        17,974

$        11,386

$        59,814


 

 

 

 

 

 

 

Fiscal Year 2012


 

Q1

Q2

Q3

Q4

Total

Net income (loss)

$        31,849

$        14,318

$      (27,771)

$      (11,704)

$          6,692


 

 

 

 

 

 

Adjustments:


 

 

 

 

 

Income tax expense (benefit)

1,731

2,047

2,119

(4,145)

1,752

Interest expense, net

7,357

7,251

6,974

6,810

28,392

Depreciation and amortization expense

11,159

11,852

10,373

10,740

44,124

Restructuring charges

1,025

1,605

10,748

876

14,254

Write down of long lived assets

-

-

15,786

-

15,786

ERP integration costs

1,205

1,918

1,812

2,772

7,707

Plant start-up costs

-

718

666

2,190

3,574

Acquisition related fees

610

-

-

866

1,476

Stock-based compensation expense (recovery)

1,191

984

(797)

1,697

3,075

Loss (gain) on sales and disposals of assets

123

(40)

9

226

318

Net foreign exchange (gain) loss

(123)

1,391

303

(652)

919

Registration related fees

204

77

-

-

281

Adjusted EBITDA

$        56,331

$        42,121

$        20,222

$          9,676

$      128,350

 

 

SOURCE KEMET Corporation



RELATED LINKS
http://www.kemet.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.